Indegene IPO
About the company
Indegene Limited provides digital-led commercialization services to the life sciences industry. They aid with various services such as drug development, clinical trials, regulatory support, sales and marketing support, complaints management, etc., basically focused on modernizing healthcare operations. The company has a unique business model and enjoys virtual monopoly in its business that generates over 98% global revenue. It marked steady growth in its top and bottom lines for the reported periods, and the segment is poised for bright prospects ahead.
The company's services can be divided into the following categories:
- Enterprise Commercial Solutions
- Omnichannel Activation
- Enterprise Medical Solutions
- Enterprise Clinical Solutions and consultancy services
IPO details
Indegene IPO is a main-board IPO of 40,746,891 equity shares of the face value of ₹2 aggregating up to ₹1,841.76 Crores.
- IPO Date - Indegene IPO opens on 6th may, 2024 and the last date to apply is 8th May, 2024.
- IPO Listing Date - Indegene would be listed on NSE and BSE on 13th May, 2024.
- Price Band - The price band for Indegene IPO is 430-452 rs per share
- Lot size - Investors can bid in a lot of 33 shares for a minimum of 1 lot and a maximum of 13 lots for retail investors.
Indegene IPO GMP Details
As of 6th May, 2024, the Grey Market Premium for Indegene stands at ₹260. Considering the upper band of the IPO and the existing GMP, analysts suggest that Indegene's IPO could list at an approximate price of ₹712 per share, indicating strong investor interest and confidence in the company's future prospects.
Key Performance Indicators
- Market Cap of Indegene IPO - Rs 10814.07 Cr.
- P/E ratio - 33.53
- EPS - 13.48
- Debt/Equity - 0.3
- PAT Margin (Profit After Tax) - 12.62
- P/BV - 7.55
Indegene Financial Statements
Indegene Limited's revenue increased by 39.85% and profit after tax (PAT) rose by 63.43% between the financial year ending with March 31, 2023 and March 31, 2022.
